Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Neoadjuvant Ipilimumab Plus Nivolumab Results in Longer EFS Than Adjuvant Nivolumab...

Ogkologos - 10 Ιουνίου, 2024

Anal Cancer Advances Open Door to Screening and Prevention

Ogkologos - 7 Ιουνίου, 2024

EMA Recommends Extension of Therapeutic Indications for Tislelizumab

Ogkologos - 7 Ιουνίου, 2024

Osimertinib After Definitive Chemoradiotherapy Prolongs PFS in Patients with Unresectable Stage...

Ogkologos - 6 Ιουνίου, 2024

ESMO Gynaecological Cancers Congress 2024, 20-22 June, Florence, Italy

Ogkologos - 6 Ιουνίου, 2024

Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses

Ogkologos - 5 Ιουνίου, 2024

Avelumab Ineffective in Patients with MSS Endometrial Cancer Carrying TP53 Mutation

Ogkologos - 5 Ιουνίου, 2024

Adding Atezolizumab to Chemotherapy Does Not Improve Outcomes in Patients Who...

Ogkologos - 4 Ιουνίου, 2024

FDA Grants Accelerated Approval to Lisocabtagene Maraleucel for Follicular Lymphoma

Ogkologos - 3 Ιουνίου, 2024

Leading Change in Cancer Clinical Research, Because Our Patients Can’t Wait

Ogkologos - 31 Μαΐου, 2024

1...808182...440 Σελίδα 81 από 440

MOST POPULAR

New Translations of the ESMO Patient Guides Available in Estonian

28 Αυγούστου, 2026

Can the New “Omics” on the Block Find Liver Cancer in...

15 Μαΐου, 2023

Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for...

19 Μαΐου, 2026

Zilovertamab Vedotin Is Safe and Demonstrates Activity In Heavily Pretreated Patients...

18 Οκτωβρίου, 2021

Φόρτωση περισσοτέρων

Neoadjuvant Ipilimumab Plus Nivolumab Results in Longer EFS Than Adjuvant Nivolumab...

Anal Cancer Advances Open Door to Screening and Prevention

EMA Recommends Extension of Therapeutic Indications for Tislelizumab

Osimertinib After Definitive Chemoradiotherapy Prolongs PFS in Patients with Unresectable Stage...

ESMO Gynaecological Cancers Congress 2024, 20-22 June, Florence, Italy

Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses

Avelumab Ineffective in Patients with MSS Endometrial Cancer Carrying TP53 Mutation

Adding Atezolizumab to Chemotherapy Does Not Improve Outcomes in Patients Who...

FDA Grants Accelerated Approval to Lisocabtagene Maraleucel for Follicular Lymphoma

Leading Change in Cancer Clinical Research, Because Our Patients Can’t Wait

MOST POPULAR

New Translations of the ESMO Patient Guides Available in Estonian

Can the New “Omics” on the Block Find Liver Cancer in...

Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for...

Zilovertamab Vedotin Is Safe and Demonstrates Activity In Heavily Pretreated Patients...

HOT NEWS

An unexpected find: clues about the genetics of children’s cancer found...

Today is Veterans Day

Selpercatinib Approved for Thyroid and Lung Cancers with RET Gene Alterations

Gentle regular exercise could reduce the risk of liver cancer in...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ